Greater Manchester Diagnostics Programme

Our Strategic Objectives

  • Develop diagnostic strategy and SMART objectives to inform GM cancer strategy 2021-8

  • Modernise, plan and coordinate infrastructure equipment and technology (PACS, equipment, location and shared services)

  • Establish diagnostic performance metrics and tracking, STT single queue diagnostics and alignment with local/regional cancer MDTs

  • Support development of workforce and finance / commissioning strategies.

Expected Benefits

  • Equitable patient access to specialist procedures

  • Procedures delivered within cancer access target

  • A GM 5 year overarching strategy and updated diagnostics plan to support the eight domains, focusing on the four covering the cancer pathways (prevention, earlier/faster diagnosis, improved/standardised care and living with cancer/surveillance), and linking to the cross cutting domains (commissioning, patient experience, research and education).

  • GAP analysis of the full GM work programme and thus combined ask of Diagnostics broken down and aligned to Prevention, Earlier Diagnosis, Treatment, Personalise & Ongoing Care and EDUCATION.

  • Diagnostic understanding within all high priority elements such as Screening, Long Waits, Surveillance.

  • IS collaboration

  • Strategic positioning within key influencers – GM Imaging & Pathology Cells

  • GAP analysis of the full GM work programme and thus combined ask of Diagnostics broken down and aligned to Prevention, Earlier Diagnosis, Treatment, Personalise & Ongoing Care and EDUCATION.

  • Close working with Diagnostic Trusts Leads across NW

  • GM Diagnostics Dashboard considering every Pathway

  • Workforce planning; sustainability, new innovation.

  • Point of influence for interdependency programmes:

    • Community Diagnostic Hubs
    • Single Queue Diagnostics
    • RDC’s
    • Lung, Colorectal…Pathways
    • GM wide IT System

Key People

Dr Rhidian Bramley MBChB MRCP FRCR

Clinical Lead for Diagnostics, Digital and Innovation, Greater Manchester Cancer

Consultant Radiologist, The Christie NHS Foundation Trust, Manchester M20 4BX

Diagnostics Summary

In conjunction with the imaging cell, endoscopy and pathology groups, we are linking the GM cancer priorities with recovery plans and collaborating in the following areas:

  • Cancer Pathways (best timed diagnostic pathways, lung health checks)

  • Clinical Transformation (equity of access, performance and outcomes)

  • Data Analytics (agreed performance metrics, live NW dashboard, cancer waiting times)

  • Digital Enablement (PACS, single queue diagnostics, cross enterprise workflow, AI)

  • Equipment (replacement and fair allocation, use of independent sector, RDC and CDH)

  • Workforce (resilience, retention, new roles and ways of working, skill-mix)

Diagram showing diagnostic networks structure

Documents